INS and metabolic dysfunction-associated steatotic liver disease: While the FT4 levels in the patients with ET and NAFLD were lower than those in the patients with ET without NAFLD, the patients with ET and NAFLD had increased FT3/FT4 ratios, as well as uric acid, fasting insulin and HOMA-IR levels, compared to the patients with ET without NAFLD (p=0.01).